Value screen
Companies growing revenue that are cheap relative to their own trading history — on earnings where earnings exist, on sales where they do not yet. Point-in-time by construction: every figure is dated to when the filing became public.
Read this before reading the table
This is a research screen for finding filings worth reading — not advice, and not a validated strategy. The buy-cheap / sell-rich rotation behind it has not been backtested yet, so nothing here carries a measured win rate or expectancy. A low multiple is a question (“why is this cheap?”), never an answer.
Biotech and unmapped/shell filers are excluded by default: pre-revenue companies have no meaningful P/E or P/S, so they would rank on noise.
Screening the market…